Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS

Savona, M. R., Pollyea, D. A., Stock, W., Oehler, V. G., Schroeder, M. A., Lancet, J., McCloskey, J., Kantarjian, H. M., Ma, W. W., Shaik, M. N., Laird, A. D., Zeremski, M., O'Connell, A., Chan, G., Cortes, J. E.
The American Association for Cancer Research (AACR)
Published 2018